Patents by Inventor Gordon Sydney Anderson Birnie Stewart

Gordon Sydney Anderson Birnie Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020064567
    Abstract: Antiviral and antifungal compositions comprise a ferrous salt and a plant extract of pomegranate rind, Viburnum plicatum leaves or flowers, tea leaves or maple leaves in aqueous solution.
    Type: Application
    Filed: October 11, 2001
    Publication date: May 30, 2002
    Inventors: Sabah Abdel Amir Jassim, Stephen Paul Denyer, Gordon Sydney Anderson Birnie Stewart
  • Patent number: 6187316
    Abstract: Antiviral and antifungal compositions comprising a mixture of a ferrous salt and an aqueous plant extract of pomegranate rind, Viburnum plicatum leaves or flowers, tea leaves or maple leaves are disclosed.
    Type: Grant
    Filed: August 25, 1998
    Date of Patent: February 13, 2001
    Assignee: Merck Patent GmbH
    Inventors: Sabah Abdel Amir Jassim, Stephen Paul Denyer, Gordon Sydney Anderson Birnie Stewart
  • Patent number: 5969158
    Abstract: A compound having formula (1) for use as a medicament wherein n is 2 or 3; Y is O, S or NH; X is O, S or NH; and R is C.sub.1 -C.sub.18 alkyl or acyl which may be substituted.
    Type: Grant
    Filed: June 15, 1998
    Date of Patent: October 19, 1999
    Assignee: The University of Nottingham
    Inventors: Barrie Walsham Bycroft, Herbert Fitzgerald Sewell, Gordon Sydney Anderson Birnie Stewart, Paul Williams
  • Patent number: 5948649
    Abstract: A method of identifying a nucleic acid sequence in a biological sample comprises using a pair of universal oligonucleotide primers to amplify the nucleic acid sequence and characterizing the amplification reaction products. Preferred universal primers are derived from conserved regions of cold shock or Y-box proteins and hybridize to the genes that code for the peptide sequences GXVKWFNXXKGFGFI and GPXAXNVTXX.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: September 7, 1999
    Assignee: Biotec Laboratories Limited
    Inventors: Gordon Sydney Anderson Birnie Stewart, Kevin Patrick Francis
  • Patent number: 5840308
    Abstract: Antiviral and antifungal compositions comprising a mixture of a ferrous salt and a plant extract of pomegranate rind, Viburnum plicatum leaves or flowers, tea leaves, or maple leaves in an aqueous solution are disclosed. The compositions are mainly used to prevent the growth of, or kill, viruses or fungi on surfaces. The compositions do not substantially affect bacterial viability as measured by colony forming ability.
    Type: Grant
    Filed: September 17, 1996
    Date of Patent: November 24, 1998
    Assignee: Merck Patent GmbH
    Inventors: Sabah Abdel Amir Jassim, Stephen Paul Denyer, Gordon Sydney Anderson Birnie Stewart
  • Patent number: 5827678
    Abstract: The invention is directed to an assay reagent comprising bacteria cells which have been killed but which retain a functional metabolic activity. The assay reagent is useful in a method for assaying an analyte when the functional metabolic activity of the killed cells is signal-generating. A kit for assaying an analyte using the assay reagent of the invention is also provided.
    Type: Grant
    Filed: July 9, 1996
    Date of Patent: October 27, 1998
    Assignee: Merck Patent GmbH
    Inventors: Ian Philip Hesslewood, Gordon Sydney Anderson Birnie Stewart
  • Patent number: 5776974
    Abstract: A compound having formula (1) for use as a medicament wherein n is 2 or 3; Y is O, S or NH; X is O, S or NH; and R is C.sub.1 -C.sub.18 alkyl or acyl which may be substituted.
    Type: Grant
    Filed: February 5, 1996
    Date of Patent: July 7, 1998
    Assignee: The University of Nottingham
    Inventors: Barrie Walsham Bycroft, Herbert Fitzgerald Sewell, Gordon Sydney Anderson Birnie Stewart, Paul Williams
  • Patent number: 5723330
    Abstract: A method for testing for target bacteria involves adding bacteriophage to a sample to infect the bacteria in the sample; killing extracellular bacteriophage without killing phage-infected bacteria; amplifying bacteriophage remaining in the sample; and causing the bacteriophage to infect reporter bacteria and thereby produce an observable signal. The reporter bacteria are genetically engineered to have an indicator gene which on expression gives rise to a detectable signal, wherein expression of the indicator gene is initiated on bacteriophage infection of the bacteria.
    Type: Grant
    Filed: December 19, 1995
    Date of Patent: March 3, 1998
    Assignee: Merck Patent GmbH
    Inventors: Catherine Elizabeth Dunn Rees, Katalin Rostas-Mulligan, Simon Fearon Park, Stephen Paul Denyer, Gordon Sydney Anderson Birnie Stewart, Sabah Abdel Amir Jassim